Taiho Pharmaceutical Co., Ltd.
USPTO PatentsView assignee record - 136 granted patents across 16 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Taiho ranks #2,834 of 49,997 tracked US assignees by granted-patent volume, with 136 patents across 16 technology areas.
- #2,834
- of 49,997 US assignees by volume
- Top 29%
- by Innovation Score (43.2/100)
- 14.0
- avg claims per patent
- -35%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R2834 · Foreign Corporation #2,834 · 136 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MID 136 grants
- TOP-DECILE #2,834/49,997
- PHOTO-FINISH Shell USA
- CPC-FOCUS A61P · 16 areas
- INNOV-PAR 43.2/100
- CLAIMS-RICH 14.0 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DOWN -35% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Shell USA, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Taiho’s 43.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Taiho
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Hadal · near
Hadal · near
43 score
- MacDon Industries · near
MacDon Industries · near
43 score
- Meijo University · near
Meijo University · near
43 score
- Taiho Pharmaceutical · this assignee
Taiho Pharmaceutical · this assignee
43 score
- Volterra Semiconductor · near
Volterra Semiconductor · near
43 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Taiho's Innovation Score is 43.2/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Taiho?
Each dot is one of Taiho’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Taiho’s own 14.0 claims/patent is ABOVE the 12.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Taiho's grants concentrate
Taiho Pharmaceutical Co., Ltd. is a focused PatentsView assignee: 16 CPC subclasses with 85.3% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (20 grants) versus a trough of 6 in 2022. By volume, Taiho sits between Shell USA, Inc. and Freni Brembo S.P.A..
Taiho's three-year grant acceleration
From 2019–2021 to 2022–2024, Taiho Pharmaceutical Co., Ltd. moved from 44 to 24 grants (0.55x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,581. See the growth leaderboard.
Who files at Taiho's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Shell USA
Shell USA, Inc.
136 patents
- SK Chemicals
SK Chemicals Co., Ltd.
136 patents
- Syracuse Universi…
Syracuse University
136 patents
- Sion Power
Sion Power Corporation
136 patents
- Taiho Pharmaceuti… ◀
Taiho Pharmaceutical Co., Ltd.
136 patents
- Baylor University
Baylor University
135 patents
- Chemocentryx
Chemocentryx, Inc.
135 patents
- Forum US
Forum US, Inc.
135 patents
- Freni Brembo S P A
Freni Brembo S.P.A.
135 patents
What this shows Taiho holds 136 patents at rank #2,834, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Taiho
By rank, the assignees closest to #2,834 in granted patent volume.
- Shell USA, Inc. #2,830 · 136 patents
- SK Chemicals Co., Ltd. #2,831 · 136 patents
- Syracuse University #2,832 · 136 patents
- Sion Power Corporation #2,833 · 136 patents
- Baylor University #2,835 · 135 patents
- Chemocentryx, Inc. #2,836 · 135 patents
- Forum US, Inc. #2,837 · 135 patents
- Freni Brembo S.P.A. #2,838 · 135 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Taiho's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Taiho, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Taiho ranks #133 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (43 here).
Similar claim depth
Nearest assignees by average claims per patent (14.0 here).
Taiho's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
43 Top 29% higher than 71% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 12 | 8.8% |
| 2016 | 10 | 7.4% |
| 2017 | 20 | 14.7% |
| 2018 | 17 | 12.5% |
| 2019 | 18 | 13.2% |
| 2020 | 11 | 8.1% |
| 2021 | 15 | 11.0% |
| 2022 | 6 | 4.4% |
| 2023 | 8 | 5.9% |
| 2024 | 10 | 7.4% |
| 2025partial year | 9 | 6.6% |
Which technologies does Taiho Pharmaceutical Co., Ltd. patent most?
Top 15 of 16 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Taiho Pharmaceutical Co., Ltd.'s patent record in context - here's where to go next.
- Taiho Pharmaceutical Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 85.3% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #2,834 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Taiho Pharmaceutical Co., Ltd. against Shell USA, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 43.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.